Marialessandra Contino

Bicalutamide failure in prostate cancer treatment: involvement of Multi Drug Resistance proteins.

Giancarlo Albo, Francesco Berardi, Roberto Perrone, 2008, European journal of pharmacology.

Perspectives of P-glycoprotein modulating agents in oncology and neurodegenerative diseases: pharmaceutical, biological, and diagnostic potentials.

Francesco Berardi, Roberto Perrone, F. Berardi, 2010, Journal of medicinal chemistry.

Inhibition of hERG potassium channel by the antiarrhythmic agent mexiletine and its metabolite m-hydroxymexiletine

Francesco Tadini-Buoninsegni, Giovanni Lentini, N. Colabufo, 2015, Pharmacology research & perspectives.

Structure-activity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides, a class of 5-HT7 receptor agents. 2.

Francesco Berardi, Roberto Perrone, E. Lacivita, 2007, Journal of medicinal chemistry.

Biomarkers for the early diagnosis of Alzheimer's disease: The challenge of XXI century

M. Leopoldo, N. Colabufo, M. Contino, 2013 .